Loading company…
Valo Health uses human-centric data and AI to support drug discovery and development.
Valo Health develops the Opal Computational Platform, which combines machine learning and patient data to support therapeutic programs across major disease areas. Founded in 2019 and based in Massachusetts, US, it received Series B funding from Koch Disruptive Technologies in March 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in